Mielóma multiplex: vizsgálatok itt: Kanada

In Kanada 48 Also abroad 703

48 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

1. fázisTaking people
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Where
Hamilton, Ottawa
Életkor
18 év and over
People
250 worldwide
Run by
AbbVie
See details and how to joinNCT05650632 · EU 2023-504674-38-00
3. fázisTaking people
Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple Myeloma
Where
Hamilton
Életkor
18 év and over
People
380 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07555938 · EU 2025-524028-23-00
3. fázisTaking people
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma
Where
Ottawa, Toronto
Életkor
18 év and over
People
410 worldwide
Run by
Regeneron Pharmaceuticals
See details and how to joinNCT05730036 · EU 2022-501396-62-00
3. fázisTaking people
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Where
Calgary, Edmonton, Oshawa, Québec, Vancouver
Életkor
18 év and over
People
1590 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT05552222 · EU 2023-503442-30-00
3. fázisTaking people
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Where
Calgary, Halifax, Hamilton, London, Montreal, Toronto, Vancouver
Életkor
18 év and over
People
400 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07258511 · EU 2025-522007-18-00
3. fázisTaking people
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
Where
Greenfield Park, Montreal, Québec
Életkor
18 év and over
People
810 worldwide
Run by
Celgene
See details and how to joinNCT05519085
1/2. fázisTaking people
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Where
Hamilton, Montreal, Nova Scotia, Ottawa, Toronto
Életkor
18 év and over
People
226 worldwide
Run by
AstraZeneca
See details and how to joinNCT06106945 · EU 2023-508590-89-00
3. fázisTaking people
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
Where
Calgary, Halifax, Hamilton, Montreal, Vancouver
Életkor
18 év and over
People
440 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06615479 · EU 2024-515279-37-00
No phaseTaking people
Collection of Tissue Samples for Cancer Research
Where
Toronto
Életkor
2 hónap and over
People
5000 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT00900198
3. fázisTaking people
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Where
Calgary, Edmonton, Fredericton, Halifax, Sherbrooke, Toronto
Életkor
18 év and over
People
1060 worldwide
Run by
Pfizer
See details and how to joinNCT05623020 · EU 2024-514139-50-00
1/2. fázisTaking people
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Where
Edmonton, Toronto, Vancouver
Életkor
18 év and over
People
246 worldwide
Run by
BeOne Medicines
See details and how to joinNCT04973605 · EU 2023-507751-30-00
No phaseTaking people
Prehab Prior to Stem Cell Transplantation in Multiple Myeloma
Where
Edmonton
Életkor
18 év and over
People
30
Run by
University of Alberta
See details and how to joinNCT06280924
1. fázisTaking people
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
Where
Edmonton, Toronto
Életkor
18 év and over
People
165 worldwide
Run by
K36 Therapeutics, Inc.
See details and how to joinNCT05651932 · EU 2022-500801-41-00
3. fázisTaking people
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
Where
Calgary, Halifax, Montreal, Sherbrooke
Életkor
18 év to 130 év
People
750 worldwide
Run by
AstraZeneca
See details and how to joinNCT07735637
1. fázisTaking people
A Study Evaluating the Safety, Pharmacokinetics, and Activity of Cevostamab in Participants With Relapsed or Refractory Multiple Myeloma
Where
Edmonton, Hamilton, Toronto
Életkor
18 év and over
People
186 worldwide
Run by
Genentech, Inc.
See details and how to joinNCT04910568 · EU 2023-507019-36-00
3. fázisTaking people
Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma
Where
Barrie, Brampton, Edmonton, Hamilton, Kelowna, Kingston, Kitchener, London, Mississauga, Moncton, Montreal, Newmarket, Oakville, Oshawa, Ottawa, Québec, Regina, Saint John, Saskatoon, Sault Ste. Marie, St. Catharines, St. John's, Thunder Bay, Toronto, Vancouver, Windsor, Winnipeg
Életkor
18 év and over
People
570
Run by
Canadian Cancer Trials Group
See details and how to joinNCT06182774
3. fázisTaking people
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Where
Fredericton, Montreal
Életkor
18 év and over
People
63 worldwide
Run by
CSL Behring
See details and how to joinNCT07648264 · EU 2026-525626-38-00
3. fázisTaking people
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
Where
Montreal, Winnipeg
Életkor
18 év and over
People
183 worldwide
Run by
Takeda
See details and how to joinNCT06980480 · EU 2024-518420-80-00
2. fázisTaking people
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Where
Calgary, Montreal
Életkor
18 év and over
People
230 worldwide
Run by
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT06297226
No phaseTaking people
Preliminary Assessment of [18F]BL40 in PET/CT Scans
Where
Vancouver
Életkor
19 év to 100 év
People
30
Run by
British Columbia Cancer Agency
See details and how to joinNCT06224309
No phaseTaking people
PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)
Where
Toronto
Életkor
18 év and over
People
30
Run by
University Health Network, Toronto
See details and how to joinNCT06871176
3. fázisTaking people
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Where
Calgary, Montreal, Toronto, Vancouver
Életkor
18 év and over
People
508 worldwide
Run by
AstraZeneca
See details and how to joinNCT07391657
2. fázisTaking people
Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma
Where
Hamilton, Kingston, London, Ottawa, Vancouver, Victoria
Életkor
18 év and over
People
40
Run by
Ontario Clinical Oncology Group (OCOG)
See details and how to joinNCT06421675
No phaseTaking people
Liquid Biopsy Evaluation and Repository Development at Princess Margaret
Where
Toronto
Életkor
18 év and over
People
2500
Run by
University Health Network, Toronto
See details and how to joinNCT03702309
3. fázisTaking people
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Where
Calgary, Edmonton, Oshawa, Toronto
Életkor
18 év and over
People
700 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07518186